Tenet Healthcare Corporation

NYSE:THC Rapporto sulle azioni

Cap. di mercato: US$14.6b

Tenet Healthcare Gestione

Gestione criteri di controllo 2/4

Tenet Healthcare Il CEO è Saum Sutaria, nominato in Sep2021, e ha un mandato di 3.17 anni. la retribuzione annua totale è $ 18.52M, composta da 8.1% di stipendio e 91.9% di bonus, comprese azioni e opzioni aziendali. possiede direttamente 0.29% delle azioni della società, per un valore di $ 41.64M. La durata media del mandato del team dirigenziale e del consiglio di amministrazione è rispettivamente 3.7 anni e 6.5 anni.

Informazioni chiave

Saum Sutaria

Amministratore delegato

US$18.5m

Compenso totale

Percentuale dello stipendio del CEO8.1%
Mandato del CEO3.2yrs
Proprietà del CEO0.3%
Durata media del management3.7yrs
Durata media del Consiglio di amministrazione6.5yrs

Aggiornamenti recenti sulla gestione

Recent updates

Here's Why Tenet Healthcare (NYSE:THC) Has A Meaningful Debt Burden

Nov 17
Here's Why Tenet Healthcare (NYSE:THC) Has A Meaningful Debt Burden

Tenet Healthcare: Targeting More Stable Demand In High-Acuity Services

Nov 04

With EPS Growth And More, Tenet Healthcare (NYSE:THC) Makes An Interesting Case

Oct 30
With EPS Growth And More, Tenet Healthcare (NYSE:THC) Makes An Interesting Case

Tenet Healthcare: Becoming A Very Healthy Business

Sep 09

Earnings Working Against Tenet Healthcare Corporation's (NYSE:THC) Share Price

Sep 06
Earnings Working Against Tenet Healthcare Corporation's (NYSE:THC) Share Price

Tenet Healthcare: Strong EPS Growth, But Shares Near FV (Rating Downgrade)

Aug 29

Here's Why Tenet Healthcare (NYSE:THC) Has A Meaningful Debt Burden

Aug 13
Here's Why Tenet Healthcare (NYSE:THC) Has A Meaningful Debt Burden

An Intrinsic Calculation For Tenet Healthcare Corporation (NYSE:THC) Suggests It's 42% Undervalued

Jul 11
An Intrinsic Calculation For Tenet Healthcare Corporation (NYSE:THC) Suggests It's 42% Undervalued

Tenet Healthcare: Asset Sales, Current Multiples Support Re-Rating (Rating Upgrade)

Jun 17

With EPS Growth And More, Tenet Healthcare (NYSE:THC) Makes An Interesting Case

May 21
With EPS Growth And More, Tenet Healthcare (NYSE:THC) Makes An Interesting Case

Tenet Healthcare Corporation's (NYSE:THC) Shareholders Might Be Looking For Exit

Apr 30
Tenet Healthcare Corporation's (NYSE:THC) Shareholders Might Be Looking For Exit

Does Tenet Healthcare (NYSE:THC) Have A Healthy Balance Sheet?

Mar 18
Does Tenet Healthcare (NYSE:THC) Have A Healthy Balance Sheet?

Tenet Healthcare: Shrinking To Grow

Feb 04

Tenet Healthcare Corporation (NYSE:THC) Might Not Be As Mispriced As It Looks

Dec 18
Tenet Healthcare Corporation (NYSE:THC) Might Not Be As Mispriced As It Looks

We Think Tenet Healthcare (NYSE:THC) Is Taking Some Risk With Its Debt

Nov 15
We Think Tenet Healthcare (NYSE:THC) Is Taking Some Risk With Its Debt

Tenet Healthcare: A Compelling Opportunity Despite Lofty Debt

Oct 13

Is Tenet Healthcare (NYSE:THC) Using Too Much Debt?

Aug 02
Is Tenet Healthcare (NYSE:THC) Using Too Much Debt?

Tenet Healthcare: Muted Earnings Outlook Doesn't Inspire Confidence For Now

Jul 28

Does This Valuation Of Tenet Healthcare Corporation (NYSE:THC) Imply Investors Are Overpaying?

Apr 13
Does This Valuation Of Tenet Healthcare Corporation (NYSE:THC) Imply Investors Are Overpaying?

USPI and Providence extend hands to aid ambulatory surgical services

Feb 09

Analisi delle retribuzioni degli amministratori delegati

Come è cambiata la remunerazione di Saum Sutaria rispetto agli utili di Tenet Healthcare?
DataCompenso totaleStipendioGuadagni aziendali
Sep 30 2024n/an/a

US$3b

Jun 30 2024n/an/a

US$3b

Mar 31 2024n/an/a

US$3b

Dec 31 2023US$19mUS$2m

US$611m

Sep 30 2023n/an/a

US$469m

Jun 30 2023n/an/a

US$499m

Mar 31 2023n/an/a

US$414m

Dec 31 2022US$11mUS$1m

US$410m

Sep 30 2022n/an/a

US$558m

Jun 30 2022n/an/a

US$875m

Mar 31 2022n/an/a

US$957m

Dec 31 2021US$21mUS$1m

US$915m

Sep 30 2021n/an/a

US$1b

Jun 30 2021n/an/a

US$434m

Mar 31 2021n/an/a

US$402m

Dec 31 2020US$9mUS$1m

US$399m

Sep 30 2020n/an/a

-US$18m

Jun 30 2020n/an/a

-US$48m

Mar 31 2020n/an/a

-US$112m

Dec 31 2019US$14mUS$962k

-US$226m

Compensazione vs Mercato: La retribuzione totale di Saum ($USD 18.52M ) è superiore alla media delle aziende di dimensioni simili nel mercato US ($USD 12.73M ).

Compensazione vs guadagni: La retribuzione di Saum è aumentata di oltre il 20% nell'ultimo anno.


AMMINISTRATORE DELEGATO

Saum Sutaria (51 yo)

3.2yrs

Mandato

US$18,518,110

Compensazione

Dr. Saumya Sutaria, M.D., also known as Saum, serves as Member of Advisory Board at Vida Health, Inc. Dr. Sutaria served as Chief Operating Officer at Tenet Healthcare Corp. since January 06, 2019 until S...


Gruppo dirigente

NomePosizioneMandatoCompensazioneProprietà
Saumya Sutaria
Chairman & CEO3.2yrsUS$18.52m0.29%
$ 41.6m
Paola Arbour
Executive VP & Chief Information Officer6.5yrsUS$2.47m0.023%
$ 3.3m
Thomas Arnst
EVP, Chief Administrative Officer3.7yrsUS$3.67mNessun dato
Lisa Foo
Executive Vice President of Commercial Operations2.7yrsUS$3.24m0.016%
$ 2.4m
Sun Park
Executive VP & CFOless than a yearNessun datoNessun dato
William McDowell
Vice President of Investor Relationsno dataNessun datoNessun dato
Jana Durfee
Senior VP & Chief Compliance Officerno dataNessun datoNessun dato
Michael Maloney
Executive Vice President of Corporate Development7.8yrsNessun datoNessun dato
Clint Hailey
Chief Managed Care Officer & Senior VP17.3yrsNessun datoNessun dato
Liz Johnson
Chief Applied Clinical Informatics Officerno dataNessun datoNessun dato
Andrew Johnston
Chief Administrative Officer - USPI1.8yrsNessun datoNessun dato
Ernest Franklin
Senior Vice President & Chief Clinical Operations Officer5.8yrsNessun datoNessun dato

3.7yrs

Durata media

55yo

Età media

Gestione esperta: Il team dirigenziale di THC è considerato esperto (durata media dell'incarico 3.7 anni).


Membri del Consiglio di amministrazione

NomePosizioneMandatoCompensazioneProprietà
Saumya Sutaria
Chairman & CEO4yrsUS$18.52m0.29%
$ 41.6m
James Bierman
Independent Director7.1yrsUS$333.54k0.040%
$ 5.8m
Stephen Rusckowski
Independent Director1.5yrsUS$238.93k0%
$ 0
Meghan FitzGerald
Independent Director6.5yrsUS$339.04k0.0081%
$ 1.2m
Joseph Kerrey
Lead Independent Director23.7yrsUS$541.53k0.024%
$ 3.5m
Richard Mark
Independent Director7yrsUS$335.04k0.018%
$ 2.6m
Richard Fisher
Independent Director7yrsUS$351.04k0.0070%
$ 1.0m
Tammy Romo
Independent Director9.7yrsUS$356.04k0.051%
$ 7.4m
Christopher Lynch
Independent Director5.3yrsUS$331.04k0.00029%
$ 42.3k
Mark Kopser
Executive Chairman of Aspen Healthcare no dataNessun datoNessun dato
Cecil Haney
Independent Director3.8yrsUS$327.04k0.0018%
$ 258.1k
Nadja West
Independent Director5.1yrsUS$320.04k0.021%
$ 3.0m

6.5yrs

Durata media

67yo

Età media

Consiglio di amministrazione esperto: I membri del consiglio di amministrazione di THC sono considerati esperti (durata media dell'incarico 6.5 anni).